<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對(duì)照品 > 對(duì)照品 > 對(duì)照藥材 >
    HX 630-d4
    產(chǎn)品基本信息
    產(chǎn)品編號(hào):H674252
    產(chǎn)品名稱(chēng):HX 630-d4
    產(chǎn)品CAS:1794787-53-3
    規(guī)格含量:
    產(chǎn)品價(jià)格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號(hào): H674252
    名稱(chēng): HX 630-d4
    別名: 4-(7,8,9,10-tetrahydro-7,7,10,10-tetramethylbenzo[b]naphtho[2,3-f][1,4]thiazepin-12-yl)benzoic Acid-d4;
    CAS號(hào): 1794787-53-3
    參考CAS號(hào): unlablled: 188844-52-2
    分子式: C??H??D?NO?S
    分子量: 445.61
    種類(lèi): Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: The labelled analogue of a nuclear receptor retinoid X receptor (RXR) agonist that exerts antiproliferative effects in vascular smooth muscle cells (VSMCs) in vivo and in vitro. A potential therapeutic target for vascular injury and intimal thickening. It efficiently enhanced ABCA1 mRNA expression and apoVIP(LA)I-dependent cellular cholesterol release in differentiated THP-1 cells.
    參考文獻(xiàn)


    2011-2018 信陽(yáng)萊耀生物科技有限公司 @ 信陽(yáng)埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對(duì)照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對(duì)照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      久久高清一区二区 | 翔田千里A片一区二区 | 久久精品三级电影 | 白丝校花被c | 国产一二三在线播放 |